Thwarting Prostate Cancer (IMAGE) Cedars-Sinai Medical Center Caption Graph shows elevated activity of a transcription-factor network that includes the molecule Onecut2 in tumors of patients whose prostate cancer resisted hormone therapy (above purple bar) compared with other types. (Michael Freeman, Ph.D.) Credit Nature Publishing Group (Nature Research) Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.